Matches in SemOpenAlex for { <https://semopenalex.org/work/W4281723522> ?p ?o ?g. }
- W4281723522 endingPage "1191" @default.
- W4281723522 startingPage "1191" @default.
- W4281723522 abstract "Two different series of fifty-two compounds, based on 3',4',5'-trimethoxyaniline (7a-ad) and variably substituted anilines (8a-v) at the 7-position of the 2-substituted-[1,2,4]triazolo [1,5-a]pyrimidine nucleus, had moderate to potent antiproliferative activity against A549, MDA-MB-231, HeLa, HT-29 and Jurkat cancer cell lines. All derivatives with a common 3-phenylpropylamino moiety at the 2-position of the triazolopyrimidine scaffold and different halogen-substituted anilines at its 7-position, corresponding to 4'-fluoroaniline (8q), 4'-fluoro-3'-chloroaniline (8r), 4'-chloroaniline (8s) and 4'-bromoaniline (8u), displayed the greatest antiproliferative activity with mean IC50's of 83, 101, 91 and 83 nM, respectively. These four compounds inhibited tubulin polymerization about 2-fold more potently than combretastatin A-4 (CA-4), and their activities as inhibitors of [3H]colchicine binding to tubulin were similar to that of CA-4. These data underlined that the 3',4',5'-trimethoxyanilino moiety at the 7-position of the [1,2,4]triazolo [1,5-a]pyrimidine system, which characterized compounds 7a-ad, was not essential for maintaining potent antiproliferative and antitubulin activities. Compounds 8q and 8r had high selectivity against cancer cells, and their interaction with tubulin led to the accumulation of HeLa cells in the G2/M phase of the cell cycle and to apoptotic cell death through the mitochondrial pathway. Finally, compound 8q significantly inhibited HeLa cell growth in zebrafish embryos." @default.
- W4281723522 created "2022-06-13" @default.
- W4281723522 creator A5002481584 @default.
- W4281723522 creator A5003987144 @default.
- W4281723522 creator A5007536978 @default.
- W4281723522 creator A5007677403 @default.
- W4281723522 creator A5017758211 @default.
- W4281723522 creator A5029709467 @default.
- W4281723522 creator A5032954885 @default.
- W4281723522 creator A5033631338 @default.
- W4281723522 creator A5041567500 @default.
- W4281723522 creator A5041904608 @default.
- W4281723522 creator A5043145057 @default.
- W4281723522 creator A5063620408 @default.
- W4281723522 creator A5085132723 @default.
- W4281723522 creator A5088149477 @default.
- W4281723522 date "2022-06-02" @default.
- W4281723522 modified "2023-10-14" @default.
- W4281723522 title "Synthesis and Biological Evaluation of Highly Active 7-Anilino Triazolopyrimidines as Potent Antimicrotubule Agents" @default.
- W4281723522 cites W1591187753 @default.
- W4281723522 cites W1940977745 @default.
- W4281723522 cites W1958811049 @default.
- W4281723522 cites W1969615301 @default.
- W4281723522 cites W1972163440 @default.
- W4281723522 cites W1979313505 @default.
- W4281723522 cites W1980969730 @default.
- W4281723522 cites W1982796161 @default.
- W4281723522 cites W1983134006 @default.
- W4281723522 cites W1994297035 @default.
- W4281723522 cites W1998236197 @default.
- W4281723522 cites W2004153677 @default.
- W4281723522 cites W2014859865 @default.
- W4281723522 cites W2027669300 @default.
- W4281723522 cites W2038456507 @default.
- W4281723522 cites W2040037385 @default.
- W4281723522 cites W2063935472 @default.
- W4281723522 cites W2065371863 @default.
- W4281723522 cites W2080849052 @default.
- W4281723522 cites W2082102275 @default.
- W4281723522 cites W2083031286 @default.
- W4281723522 cites W2101575450 @default.
- W4281723522 cites W2108979392 @default.
- W4281723522 cites W2115527228 @default.
- W4281723522 cites W2115764471 @default.
- W4281723522 cites W2168784593 @default.
- W4281723522 cites W2224757179 @default.
- W4281723522 cites W2341322985 @default.
- W4281723522 cites W2397319312 @default.
- W4281723522 cites W2400356771 @default.
- W4281723522 cites W2418632957 @default.
- W4281723522 cites W2529386894 @default.
- W4281723522 cites W2534012030 @default.
- W4281723522 cites W2575200304 @default.
- W4281723522 cites W2621311359 @default.
- W4281723522 cites W2622590597 @default.
- W4281723522 cites W2753841677 @default.
- W4281723522 cites W2754785899 @default.
- W4281723522 cites W2799809717 @default.
- W4281723522 cites W2806574348 @default.
- W4281723522 cites W2888769288 @default.
- W4281723522 cites W2905130778 @default.
- W4281723522 cites W2910046601 @default.
- W4281723522 cites W2972541435 @default.
- W4281723522 cites W2981120951 @default.
- W4281723522 cites W2985502273 @default.
- W4281723522 cites W2989313910 @default.
- W4281723522 cites W2996972660 @default.
- W4281723522 cites W3005822147 @default.
- W4281723522 cites W3013038172 @default.
- W4281723522 cites W3017052329 @default.
- W4281723522 cites W3020969291 @default.
- W4281723522 cites W3032920186 @default.
- W4281723522 cites W3043846144 @default.
- W4281723522 cites W3082803849 @default.
- W4281723522 cites W3128646645 @default.
- W4281723522 cites W3156472232 @default.
- W4281723522 cites W3164915896 @default.
- W4281723522 cites W3175634565 @default.
- W4281723522 cites W3197313036 @default.
- W4281723522 doi "https://doi.org/10.3390/pharmaceutics14061191" @default.
- W4281723522 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35745764" @default.
- W4281723522 hasPublicationYear "2022" @default.
- W4281723522 type Work @default.
- W4281723522 citedByCount "4" @default.
- W4281723522 countsByYear W42817235222022 @default.
- W4281723522 countsByYear W42817235222023 @default.
- W4281723522 crossrefType "journal-article" @default.
- W4281723522 hasAuthorship W4281723522A5002481584 @default.
- W4281723522 hasAuthorship W4281723522A5003987144 @default.
- W4281723522 hasAuthorship W4281723522A5007536978 @default.
- W4281723522 hasAuthorship W4281723522A5007677403 @default.
- W4281723522 hasAuthorship W4281723522A5017758211 @default.
- W4281723522 hasAuthorship W4281723522A5029709467 @default.
- W4281723522 hasAuthorship W4281723522A5032954885 @default.
- W4281723522 hasAuthorship W4281723522A5033631338 @default.
- W4281723522 hasAuthorship W4281723522A5041567500 @default.
- W4281723522 hasAuthorship W4281723522A5041904608 @default.
- W4281723522 hasAuthorship W4281723522A5043145057 @default.